- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01484704
The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer
December 1, 2011 updated by: Turku University Hospital
The purpose of this study is to determine how MRI changes the treatment and diagnostics of ductal breast cancer.
100 women with newly diagnosed breast cancer will participate the study.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Turku, Finland, 20521
- Recruiting
- University hospital of Turku
-
Contact:
- Nina M Brück, MD
- Email: nina.bruck@tyks.fi
-
Principal Investigator:
- Nina M Brück, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Newly diagnosted breast cancer patients
Description
Inclusion Criteria:
- Tumor size less than 2cm
- Ductal carcinoma unifocal
Exclusion Criteria:
- Previous breast cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
No treatment
|
|
MRI
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Study Registration Dates
First Submitted
November 30, 2011
First Submitted That Met QC Criteria
December 1, 2011
First Posted (Estimate)
December 2, 2011
Study Record Updates
Last Update Posted (Estimate)
December 2, 2011
Last Update Submitted That Met QC Criteria
December 1, 2011
Last Verified
November 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 63/180/2010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.